(Q36960805)

17 August 2017

Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis? (English)

1 reference

17 August 2017

0 references

1 reference

0 references

4

Jacques H Grosset

1 reference

17 August 2017

5

Eric L Nuermberger

1 reference

17 August 2017

Ian M Rosenthal

1

1 reference

17 August 2017

Ming Zhang

series ordinal

2

1 reference

17 August 2017

Deepak Almeida

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

21 August 2008

1 reference

American Journal of Respiratory and Critical Care Medicine

17 August 2017

1 reference

17 August 2017

178

1 reference

17 August 2017

9

1 reference

17 August 2017

989-993

1 reference

Tuberculosis in Africa — Combating an HIV-Driven Crisis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Potent twice-weekly rifapentine-containing regimens in murine tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Adverse Effects of Rifampin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2577731

29 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1029OC

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18723432

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1164/RCCM.200807-1029OC

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18723432

1 reference